AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA - DONOR LYMPHOCYTES TRANSDUCED WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOR REMISSION INDUCTION
Authors: LINK CJ BURT RK TRAYNOR AE DROBYSKI WR SEREGINA T LEVY JP GORDON L ROSEN ST BURNS WH CAMITTA B CASPER J HOROWITZ M JUCKETT M LAWTON C MARGOLIS D PIETRYGA D ROWLINGS P TAYLOR C FURTADO M STEFKA J GUPTABURT S KAISER H VESOLE DH
Citation: Cj. Link et al., ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA - DONOR LYMPHOCYTES TRANSDUCED WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOR REMISSION INDUCTION, Human gene therapy, 9(1), 1998, pp. 115-134
COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA
Authors: DESIKAN KR BARLOGIE B JAGANNATH S VESOLE DH SIEGEL D FASSAS A MUNSHI N SINGHAL S MEHTA J TINDLE S NELSON J BRACY D MATTOX S TRICOT G
Citation: Kr. Desikan et al., COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(4), 1998, pp. 1547-1553
FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA
Authors: JAGANNATH S VESOLE DH ZHANG M DESIKAN KR COPELAND N JAGANNATH M BRACY D JONES R CROWLEY J TRICOT G BARLOGIE B
Citation: S. Jagannath et al., FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA, Bone marrow transplantation, 20(6), 1997, pp. 445-450
PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60
Authors: GUBA SC VESOLE DH JAGANNATH S BRACY D BARLOGIE B TRICOT G
Citation: Sc. Guba et al., PERIPHERAL STEM-CELL MOBILIZATION AND ENGRAFTMENT IN PATIENTS OVER AGE 60, Bone marrow transplantation, 20(1), 1997, pp. 1-3
HIGH-DOSE MELPHALAN WITH AUTOTRANSPLANT FOR REFRACTORY MULTIPLE-MYELOMA (MM) - RESULTS OF A SOUTHWEST-ONCOLOGY-GROUP (SWOG) PHASE-II TRIAL (S8993)
Authors: VESOLE DH NAILECROMER J JOHNSON D CROWLEY J SALMON S BARLOGIE B
Citation: Dh. Vesole et al., HIGH-DOSE MELPHALAN WITH AUTOTRANSPLANT FOR REFRACTORY MULTIPLE-MYELOMA (MM) - RESULTS OF A SOUTHWEST-ONCOLOGY-GROUP (SWOG) PHASE-II TRIAL (S8993), Blood, 90(10), 1997, pp. 488-488
SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S VESOLE DH NAUCKE S CHESON B MATTOX S BRACY D SALMON S JACOBSON J CROWLEY J TRICOT G
Citation: B. Barlogie et al., SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA, Blood, 89(3), 1997, pp. 789-793
SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY
Authors: TRICOT G ALBERTS DS JOHNSON C ROE DJ DORR RT BRACY D VESOLE DH JAGANNATH S MEYERS R BARLOGIE B
Citation: G. Tricot et al., SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY, Clinical cancer research, 2(6), 1996, pp. 947-952
HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: TRICOT G JAGANNATH S VESOLE DH BRACY D DESIKAN KR SIEGEL D BARLOGIE B
Citation: G. Tricot et al., HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA, Leukemia & lymphoma, 22(1-2), 1996, pp. 25-36
AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA
Authors: VESOLE DH JAGANNATH S TRICOT G DESIKAN KR SIEGEL D BARLOGIE B
Citation: Dh. Vesole et al., AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA, Cancer investigation, 14(4), 1996, pp. 378-391
PRECEDING STANDARD THERAPY IS THE LIKELY CAUSE OF MDS AFTER AUTOTRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: GOVINDARAJAN R JAGANNATH S FLICK JT VESOLE DH SAWYER J BARLOGIE B TRICOT G
Citation: R. Govindarajan et al., PRECEDING STANDARD THERAPY IS THE LIKELY CAUSE OF MDS AFTER AUTOTRANSPLANTS FOR MULTIPLE-MYELOMA, British Journal of Haematology, 95(2), 1996, pp. 349-353
AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED
Authors: VESOLE DH TRICOT G JAGANNATH S DESIKAN KR SIEGEL D BRACY D MILLER L CHESON B CROWLEY J BARLOGIE B
Citation: Dh. Vesole et al., AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED, Blood, 88(3), 1996, pp. 838-847
FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLSUPPORT FOR MULTIPLE-MYELOMA PATIENTS OVER THE AGE OF 70
Authors: SIEGEL DS JAGANNATH S DESIKAN KR TRICOT G BRACY D MADDOX S BARLOGIE B VESOLE DH
Citation: Ds. Siegel et al., FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLSUPPORT FOR MULTIPLE-MYELOMA PATIENTS OVER THE AGE OF 70, Blood, 88(10), 1996, pp. 508-508
GRAFT-VERSUS-MYELOMA EFFECT - PROOF OF PRINCIPLE
Authors: TRICOT G VESOLE DH JAGANNATH S HILTON J MUNSHI N BARLOGIE B
Citation: G. Tricot et al., GRAFT-VERSUS-MYELOMA EFFECT - PROOF OF PRINCIPLE, Blood, 87(3), 1996, pp. 1196-1198
DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA AFTER TREATMENT WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: GAZITT Y TIAN EM BARLOGIE B READING CL VESOLE DH JAGANNATH S SCHNELL J HOFFMAN R TRICOT G
Citation: Y. Gazitt et al., DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA AFTER TREATMENT WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Blood, 87(2), 1996, pp. 805-811
GRAFT-VERSUS-MYELOMA EFFECT - PROOF OF PRINCIPLE
Authors: TRICOT G VESOLE DH JAGANNATH S MUNSHI N BARLOGIE B
Citation: G. Tricot et al., GRAFT-VERSUS-MYELOMA EFFECT - PROOF OF PRINCIPLE, Experimental hematology, 23(8), 1995, pp. 760-760
DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA PATIENTS FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE AND GM-CSF
Authors: GAZITT Y TIAN E BARLOGIE B GROVE C READING CC VESOLE DH JAGANNATH S SCHNELL J HOFFMAN R TRICOT G
Citation: Y. Gazitt et al., DIFFERENTIAL MOBILIZATION OF MYELOMA CELLS AND NORMAL HEMATOPOIETIC STEM-CELLS IN MULTIPLE-MYELOMA PATIENTS FOLLOWING TREATMENT WITH CYCLOPHOSPHAMIDE AND GM-CSF, Experimental hematology, 23(8), 1995, pp. 803-803
FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT TRANSPLANTS IN MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S VESOLE DH ZHANG M BRACY D TRICOT G BARLOGIE B
Citation: S. Jagannath et al., FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT TRANSPLANTS IN MULTIPLE-MYELOMA (MM), Experimental hematology, 23(8), 1995, pp. 862-862
POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES
Authors: TRICOT G SAWYER J JAGANNATH S BRACY D MATTOX S VESOLE DH NAUCKE S BARLOGIE B
Citation: G. Tricot et al., POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES, Experimental hematology, 23(8), 1995, pp. 867-867
10 YEARS OF AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED
Authors: VESOLE DH TRICOT G JAGANNATH S BRACY D MILLER L CHESON B CROWLEY J BARLOGIE B
Citation: Dh. Vesole et al., 10 YEARS OF AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED, Experimental hematology, 23(8), 1995, pp. 867-867
RELAPSE OF MULTIPLE-MYELOMA AFTER AUTOLOGOUS TRANSPLANTATION - SURVIVAL AFTER SALVAGE THERAPY
Authors: TRICOT G JAGANNATH S VESOLE DH CROWLEY J BARLOGIE B
Citation: G. Tricot et al., RELAPSE OF MULTIPLE-MYELOMA AFTER AUTOLOGOUS TRANSPLANTATION - SURVIVAL AFTER SALVAGE THERAPY, Bone marrow transplantation, 16(1), 1995, pp. 7-11
POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES
Authors: TRICOT G BARLOGIE B JAGANNATH S BRACY D MATTER S VESOLE DH NAUCKE S SAWYER JR
Citation: G. Tricot et al., POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES, Blood, 86(11), 1995, pp. 4250-4256
EFFICACY AND SAFETY OF HIGH-DOSE THERAPY WITH AUTOTRANSPLANTATION (AT) IN MULTIPLE-MYELOMA (MM) PATIENTS OVER AGE 60
Authors: VESOLE DH JAGANNATH S TRICOT G SIEGEL D DESIKAN DR VAUGHT L BARLOGIE B
Citation: Dh. Vesole et al., EFFICACY AND SAFETY OF HIGH-DOSE THERAPY WITH AUTOTRANSPLANTATION (AT) IN MULTIPLE-MYELOMA (MM) PATIENTS OVER AGE 60, Blood, 86(10), 1995, pp. 812-812
PURIFIED CD34(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS() LIN()
Authors: GAZITT Y READING CC HOFFMAN R WICKREMA A VESOLE DH JAGANNATH S CONDINO J LEE B BARLOGIE B TRICOT G
Citation: Y. Gazitt et al., PURIFIED CD34(-) THY(+) STEM-CELLS DO NOT CONTAIN CLONAL MYELOMA CELLS() LIN(), Blood, 86(1), 1995, pp. 381-389
TOXOPLASMA PNEUMONIA - CYTOLOGIC DIAGNOSIS BY BRONCHOALVEOLAR LAVAGE
Authors: WHEELER RR BARDALES RH NORTH PE VESOLE DH TRICOT G STANLEY MW
Citation: Rr. Wheeler et al., TOXOPLASMA PNEUMONIA - CYTOLOGIC DIAGNOSIS BY BRONCHOALVEOLAR LAVAGE, Diagnostic cytopathology, 11(1), 1994, pp. 52-55
EFFECT OF LOW-DOSE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (LD-GM-CSF) ON PLATELET TRANSFUSION-DEPENDENT THROMBOCYTOPENIA
Authors: VESOLE DH JAGANNATH S GLENN LD BARLOGIE B
Citation: Dh. Vesole et al., EFFECT OF LOW-DOSE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (LD-GM-CSF) ON PLATELET TRANSFUSION-DEPENDENT THROMBOCYTOPENIA, American journal of hematology, 47(3), 1994, pp. 203-207
Risultati: 1-25 | 26-30